European Rare Sugar Market size is projected to cross USD 270 million by 2026, according to a latest forecast report by Graphical Research.
Evolving consumer eating preferences and growing consumer spending on maintaining overall fitness and health should stimulate the market growth. Increase in the prevalence of chronic diseases has led to an increase in consumer focus on dietary supplements, which may boost the market demand.
The D-Mannose segment accounted for more than USD 120 million revenue in 2019. D-mannose, also referred to as Carubinose or Seminose, is a simple sugar which is used for treating carbohydrate-deficient glycoprotein syndrome type 1b. Some clinical trials in Europe also shown that it can be used for treating and avoiding urinary tract infections that supports the European rare sugar industry growth in the region. Additionally, D-mannose helps in promoting the growth of good bacteria. It may also be used for treating bleeding disorders and blood sugar disorder in people and is consumed in powder form or in capsules.
Rise in the demand for nutritional supplements for improving urinary tract health and treating various urinary tract related infections owing to rising prevalence of UTIs among people, which should trigger the demand for D-mannose treating and avoiding UTIs. Steady, increase in the number of individuals suffering from type 1 and type 2 diabetes in Europe pertaining to changing dietary patterns and rising obesity rates has accelerated the demand for D-Mannose for treating blood sugar related disorders.
Browse detailed statistical insights from the report, “Europe Rare Sugar Market Size By Application (Dietary supplements, Cosmetics & Personal care, Pharmaceuticals, Food & Beverages, Others), By Product (D-Mannose, Allulose, Tagatose, D-Xylose, L-Arabinose, and L-Fucose), Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2020 – 2026” along with the table of contents (ToC) @
The dietary supplements application segment size is estimated to reach USD 75 million in 2019. In the recent past few years, number of individuals suffering from diabetes has increased significantly in the region. Nearly 15% of the population living in Germany was suffering from diabetes in 2019 and accounted for over 50 thousand diabetes related deaths in 2019. Changing lifestyle and eating patterns have driven the number of people suffering from obesity and low blood sugar related disorders, which has accelerated the demand for low sugar products and sugar alternatives in Europe.
Increasing consumer focus on improving overall health pertaining to rising health consciousness and consumer willingness to spend on enhancing overall health performance should also boost the consumption of food and dietary supplements.
Rising prevalence of chronic disorders such as cardiovascular diseases, diabetes, and hypertension has influenced consumers in the country to focus on maintaining overall health performance and avoiding chronic diseases. There has been an increase in the consumption of low sugar products for dietary benefits such as avoiding and treating low blood sugar level disorders and enhancing urinary tract health
Major players in the market include Douglas Laboratories Europe, DuPont de Nemours, Inc., Tate & Lyle, Zhangjiagang Specom Biochemical Co., Ltd., Nutraceuticals Group, The Sanwa Starch Co., Ltd., Bonumose LLC, Samyang Corporation, Matsutani Chemical Industry Co., Ltd., Sweet Cures, and Ingredion Incorporated.
The European rare sugar market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2015 to 2026 for the following segments:
Europe Market, By Product
Europe Market, By Application
- Dietary supplements
- Cosmetics & Personal care
- Food & Beverages
The above information has been provided for the following countries: